Ana C. Liberman

1.7k total citations
38 papers, 1.4k citations indexed

About

Ana C. Liberman is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Ana C. Liberman has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 14 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Ana C. Liberman's work include Estrogen and related hormone effects (10 papers), Stress Responses and Cortisol (6 papers) and NF-κB Signaling Pathways (6 papers). Ana C. Liberman is often cited by papers focused on Estrogen and related hormone effects (10 papers), Stress Responses and Cortisol (6 papers) and NF-κB Signaling Pathways (6 papers). Ana C. Liberman collaborates with scholars based in Argentina, Germany and United States. Ana C. Liberman's co-authors include Eduardo Arzt, Damián Refojo, Jimena Druker, Marcelo J. Perone, Marcelo Páez-Pereda, Marta A. Toscano, Günter K. Stalla, Mathias Burgmaier, Damián Kovalovsky and Daniel Hochbaum and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ana C. Liberman

38 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana C. Liberman Argentina 18 471 424 364 204 194 38 1.4k
Hyunwon Yang South Korea 23 571 1.2× 406 1.0× 182 0.5× 194 1.0× 172 0.9× 66 2.1k
Shi‐Bin Cheng United States 25 452 1.0× 770 1.8× 146 0.4× 110 0.5× 314 1.6× 55 2.1k
Margaret Bresnahan United States 20 906 1.9× 530 1.3× 161 0.4× 139 0.7× 210 1.1× 36 2.1k
Sylvie Durant France 20 213 0.5× 405 1.0× 264 0.7× 92 0.5× 331 1.7× 46 1.4k
Cong Lin China 17 122 0.3× 693 1.6× 195 0.5× 113 0.6× 149 0.8× 63 1.5k
Kazutoshi Murakami Japan 23 199 0.4× 506 1.2× 316 0.9× 122 0.6× 64 0.3× 73 1.7k
Beth S. Schachter United States 22 165 0.4× 555 1.3× 369 1.0× 207 1.0× 602 3.1× 34 1.6k
F.J. Laso Spain 22 309 0.7× 262 0.6× 138 0.4× 149 0.7× 83 0.4× 49 1.3k
H.U. Bryant United States 18 114 0.2× 446 1.1× 288 0.8× 279 1.4× 541 2.8× 42 1.3k
I‐Chen Yu United States 19 243 0.5× 580 1.4× 286 0.8× 139 0.7× 138 0.7× 36 1.4k

Countries citing papers authored by Ana C. Liberman

Since Specialization
Citations

This map shows the geographic impact of Ana C. Liberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana C. Liberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana C. Liberman more than expected).

Fields of papers citing papers by Ana C. Liberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana C. Liberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana C. Liberman. The network helps show where Ana C. Liberman may publish in the future.

Co-authorship network of co-authors of Ana C. Liberman

This figure shows the co-authorship network connecting the top 25 collaborators of Ana C. Liberman. A scholar is included among the top collaborators of Ana C. Liberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana C. Liberman. Ana C. Liberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bajaj, Thomas, Nils C. Gassen, Theo Rein, et al.. (2022). Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity. Molecular Psychiatry. 27(5). 2533–2545. 15 indexed citations
2.
Liberman, Ana C., et al.. (2019). SUMO conjugation as regulator of the glucocorticoid receptor-FKBP51 cellular response to stress. Steroids. 153. 108520–108520. 6 indexed citations
3.
Liberman, Ana C., Emiliano Trías, Luana da Silva Chagas, et al.. (2018). Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System. NeuroImmunoModulation. 25(5-6). 246–270. 51 indexed citations
4.
Kahles, Florian, Ana C. Liberman, Matthias Rau, et al.. (2018). The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE−/− mice by blocking monocyte/macrophage activation. Molecular Metabolism. 14. 150–157. 51 indexed citations
5.
Andreone, Luz, Julie Deckers, Carla N. Castro, et al.. (2016). GR-independent down-modulation on GM-CSF bone marrow-derived dendritic cells by the selective glucocorticoid receptor modulator Compound A. Scientific Reports. 6(1). 36646–36646. 7 indexed citations
6.
Aprile-Garcia, Fernando, Michael Metzger, Marcelo Páez-Pereda, et al.. (2016). Co-Expression of Wild-Type P2X7R with Gln460Arg Variant Alters Receptor Function. PLoS ONE. 11(3). e0151862–e0151862. 22 indexed citations
7.
Druker, Jimena, Nils C. Gassen, Fernando Aprile-Garcia, et al.. (2016). The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51. Cell Death and Differentiation. 23(10). 1579–1591. 24 indexed citations
8.
Liberman, Ana C., et al.. (2014). Modulation of the Glucocorticoid Receptor Activity by Post-Translational Modifications. SHILAP Revista de lepidopterología. 1. 1–15. 9 indexed citations
10.
11.
Aprile-Garcia, Fernando, et al.. (2013). Novel insights into the neuroendocrine control of inflammation: the role of GR and PARP1. Endocrine Connections. 3(1). R1–R12. 8 indexed citations
12.
Liberman, Ana C., V. Ferraz-de-Paula, João Palermo‐Neto, et al.. (2012). Correction: Compound A, a Dissociated Glucocorticoid Receptor Modulator, Inhibits T-bet (Th1) and Induces GATA-3 (Th2) Activity in Immune Cells. PLoS ONE. 7(5). 5 indexed citations
13.
Liberman, Ana C., V. Ferraz-de-Paula, João Palermo‐Neto, et al.. (2012). Compound A, a Dissociated Glucocorticoid Receptor Modulator, Inhibits T-bet (Th1) and Induces GATA-3 (Th2) Activity in Immune Cells. PLoS ONE. 7(4). e35155–e35155. 36 indexed citations
14.
Castro, Carla N., Ana C. Liberman, Ricardo A. Dewey, et al.. (2010). Disease-Modifying Immunotherapy for the Management of Autoimmune Diabetes. NeuroImmunoModulation. 17(3). 173–176. 3 indexed citations
15.
Liberman, Ana C., et al.. (2009). Intracellular Molecular Signaling. Annals of the New York Academy of Sciences. 1153(1). 6–13. 29 indexed citations
16.
Liberman, Ana C., et al.. (2009). Glucocorticoids inhibitGATA‐3 phosphorylation and activity in T cells. The FASEB Journal. 23(5). 1558–1571. 71 indexed citations
17.
Liberman, Ana C., Jimena Druker, Damián Refojo, & Eduardo Arzt. (2008). Mecanismos moleculares de acción de algunas drogas inmunosupresoras. Medicina-buenos Aires. 68(6). 455–464. 3 indexed citations
18.
Toscano, Marta A., Alessandra G. Commodaro, Juan M. Ilarregui, et al.. (2006). Galectin-1 Suppresses Autoimmune Retinal Disease by Promoting Concomitant Th2- and T Regulatory-Mediated Anti-Inflammatory Responses. The Journal of Immunology. 176(10). 6323–6332. 162 indexed citations
19.
Druker, Jimena, Ana C. Liberman, Damiana Giacomini, et al.. (2006). Molecular Understanding of Cytokine–Steroid Hormone Dialogue. Annals of the New York Academy of Sciences. 1088(1). 297–306. 8 indexed citations
20.
Refojo, Damián, Ana C. Liberman, Damiana Giacomini, et al.. (2003). Integrating Systemic Information at the Molecular Level. Annals of the New York Academy of Sciences. 992(1). 196–204. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026